Amgen Inc.
AMGN
•Stock Analysis$277.13
+0.00 (+0.00%)• Live
Amgen Inc. Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Amgen Inc.
Key Financial Metrics
for Amgen Inc.
P/E Ratio
26.46
Revenue Growth
+18.57%
EPS Growth
-39.81%
Market Cap
$156.91B
Dividend Yield
+3.17%
Debt/Equity
9.24
ROIC
+9.53%
FCF Yield
+6.96%
View additional metrics
Valuation
P/B Ratio25.29
EV/Sales6.02
Financial Health
Current Ratio1.17
Return on Assets+13.19%
Analyst Recommendations
for Amgen Inc.
36 analysts
Consensus: Buy
About
for Amgen Inc.
Company Details
for Amgen Inc.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Robert A. Bradway
Employees
28,000
Market Cap
149.01B
Exchange
NASDAQ Global Select
IPO Date
June 17, 1983
Website
www.amgen.comCIK
0000318154
ISIN
US0311621009
CUSIP
031162100
Country
US
Balance Sheet
for Amgen Inc.
Cash Flow Statement
for Amgen Inc.
Income Statement
for Amgen Inc.
News
No news available at the moment.